About Digna Biotech
Biopharmaceutical company developing therapeutic and diagnostic products discovered at the University of Navarra's CIMA (Center for Applied Medical Research) and, less significantly, other premier Spanish academic institutions.
The company's mission is to take its first products up to clinical proof-of-concept and forge partnerships with other biopharmaceutical companies in order to complete clinical development and commercial launch.
The company is funded jointly by two Foundations linked to the University of Navarra and a group of 15 investors, and initiated operations in 2004.
Currently, it has 34 products under development, a 65 mill € investment plan (15,8 mill € up-to-date + 46,5 mill through 2010), and expects partners to launch its first diagnostic to market in 2008 and its first therapy in 2010.
- Industry : Biotechnology
Product portfolio of Digna Biotech
News about Digna Biotech
Here you will find Digna Biotech S.L.
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
